Free Newsletter
Pharma places fifth on never-to-recover job loss list
Pharma pulls up in fifth place on a 24/7 Wall St list of industries that will never recover their job losses. Authors do qualify the "never," however: "if they do it will take years or decades." It's the usual litany of patent expirations, revenue erosion via generics competition and worker-cutting mergers. Pharma trails state and local government; construction; installation, maintenance and repair; and the automotive sectors on the loss list. But it beats newspapers and bank tellers. Article
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: